Meta-Analysis of the Association between Fibroblast Growth Factor 23 and Mortality and Cardiovascular Events in Hemodialysis Patients
Conclusions: Elevated serum FGF23 levels are positively associated with all-cause mortality and cardiovascular events in hemodialysis patients, with a 14 or 39% increase in all-cause mortality and a 21% increased risk of cardiovascular events.Blood Purif
Source: Blood Purification - Category: Hematology Source Type: research
More News: Cardiology | Cardiovascular | Databases & Libraries | Dialysis | Heart | Hematology | Hemodialysis | Study